CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Revenue:
Product sales	$ 1,805,302	$ 2,492,476
Development revenue	1,421,149	793,710
Licensing revenue	928,129	69,345
Royalties	1,047,615	1,172,691
Total revenue	5,202,195	4,528,222
Cost of revenue:
Cost of product sales	1,017,437	1,427,641
Cost of development revenue	159,308	599,502
Total cost of revenue	1,176,745	2,027,143
Gross profit	4,025,450	2,501,079
Operating expenses:
Research and development	4,533,626	3,072,685
Sales and marketing	5,510,202	881,253
General and administrative	2,789,966	1,950,430
Total operating expenses	12,833,794	5,904,368
Operating loss	(8,808,344)	(3,403,289)
Other income (expense)	13,739	(5,159)
Net loss	$ (8,794,605)	$ (3,408,448)
Basic and diluted net loss per common share	$ (0.07)	$ (0.03)
Basic and diluted weighted average common shares outstanding	129,656,257	126,106,713